title: 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
abstract: OBJECTIVE
  Liver function can be evaluated using 13C breath tests that explore liver Cytochrome P450 activity. Aminopyrine is one of the first compounds used in liver function testing. Lidocaine metabolism to monoethylglycinexylidide is also a valid tool to assess liver function. Although liver Cytochrome P450 metabolizes both compounds, lidocaine metabolism is flow-dependent while aminopyrine metabolism does not depend on liver blood flow.
  
  
  METHODS
  The 1st part of the study evaluated the appearance and disappearance rate of 13CO2 in the breath of both normal subjects and in cirrhotic patients, so as to establish optimal sampling times and to evaluate the amount of time needed before performing a subsequent breath test. The 2nd part of the study compared the aminopyrine breath test with the monoethylglycinexylidide test in patients with chronic hepatitis or cirrhosis.
  
  
  RESULTS
  Complete 13CO2 disappearance was recorded 24 hours after the test in normal subjects, while it took 3 days to disappear from the breath of cirrhotic patients. Breath sampling at 60, 120 and 180 min were equally valid in differentiating chronic hepatitis from cirrhosis. The aminopyrine breath test and monoethylglycinexylidide test showed a good yet not close correlation.
  
  
  CONCLUSIONS
  This study showed that in cirrhotic patients a 13C breath test can be performed 3 days after the previous one. In chronic hepatitis and cirrhotic patients, the aminopyrine breath test and the monoethylglycinexylidide test evaluated similar, but not identical, hepatic subfunctions, suggesting that multiple 13C breath test using different substrates could explore liver function better.
authors.affiliation: Department of Internal Medicine, University of Genoa, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Fasoli
authors.forename: E
authors.initials: E
authors.lastname: Giannini
authors.forename: F
authors.initials: F
authors.lastname: Botta
authors.forename: P
authors.initials: P
authors.lastname: Romagnoli
authors.forename: D
authors.initials: D
authors.lastname: Risso
authors.forename: G
authors.initials: G
authors.lastname: Celle
authors.forename: R
authors.initials: R
authors.lastname: Testa
mesh_terms: D000328:Adult; D000632:Aminopyrine; D019540:Area Under Curve; D001944:Breath Tests; D002245:Carbon Dioxide / Q000378:metabolism; D002250:Carbon Radioisotopes; D003937:Diagnosis, Differential; D005260:Female; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000378:metabolism; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D008012:Lidocaine; D008103:Liver Cirrhosis / Q000175:diagnosis* / Q000378:metabolism; D008111:Liver Function Tests / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D012680:Sensitivity and Specificity; D018709:Statistics, Nonparametric
chemical_list: D002250:Carbon Radioisotopes; D000632:Aminopyrine; D002245:Carbon Dioxide; D008012:Lidocaine